Adaptive Biotechnologies

Yahoo Finance • last month

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose... Full story

Yahoo Finance • 2 months ago

Adaptive Biotechnologies (NASDAQ:ADPT) Fits Minervini's Trend Template with Strong Growth Momentum

Adaptive Biotechnologies Corp. (NASDAQ:ADPT [https://www.chartmill.com/stock/quote/ADPT]) has been recognized as a possible choice for investors using Mark Minervini’s trend-based approach and high-growth momentum investing. The Minervini... Full story

Yahoo Finance • 2 months ago

Piper Sandler raises Adeptus Biotechnologies stock price target on growth outlook

Investing.com - Piper Sandler raised its price target on Adeptus Biotechnologies Corp. (NASDAQ:ADPT) to $15.00 from $13.00 on Wednesday, while maintaining an Overweight rating on the stock. The company, currently valued at $1.73 billion, h... Full story

Yahoo Finance • 2 months ago

Adaptive Biotechnologies soars 8.5% as MRD business achieves profitability

Investing.com -- Adaptive Biotechnologies Corp (NASDAQ:ADPT) shares surged 8.5% after the company reported second quarter results that significantly exceeded analyst expectations, driven by strong performance in its Minimal Residual Dise... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK ETFs shuffle RBLX, COIN, and BMNR stocks

Cathie Wood’s ARK ETFs have made significant moves in the stock market on Friday, August 1, 2025, with a particular focus on tech and biotech companies. Leading the trades was a massive purchase of Coinbase Global Inc (NASDAQ:COIN) share... Full story

Yahoo Finance • 3 months ago

Adaptive Biotechnologies Corporation (ADPT) Rose on Solid Results

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S. equity market regained its strength in the second quar... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK ETF bolsters stakes in Tempus AI, buys more NVIDIA stock

Cathie Wood’s ARK ETFs have made significant moves in the stock market on Wednesday, 16 July 2025, with notable transactions across a range of sectors. The daily trade report revealed a strategic bolstering of positions in certain high-tec... Full story

Yahoo Finance • 3 months ago

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK ETF adjusts portfolio, buys Tesla and ATAI stock

Cathie Wood’s ARK ETFs have made their latest round of daily trades on Tuesday, 01 July 2025, with significant activity across a variety of sectors. In a notable move, ARK has increased its holdings in Tesla Inc (NASDAQ:TSLA) with a substa... Full story

Yahoo Finance • 3 months ago

Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®

SEATTLE, July 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose... Full story

Yahoo Finance • 4 months ago

Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers. On June 18, Craig-Hallum began coverage of Adaptive Biotechnologies Corporation (NASDAQ:ADPT)’s stock wit... Full story

Yahoo Finance • 4 months ago

Cathie Wood's ARK ETF trades Shopify, Toast stock amid tech focus

Cathie Wood’s ARK ETFs have revealed their daily trades for Tuesday, June 24th, 2025, with notable activity in the technology sector. ARK’s most significant trades of the day included purchases of Shopify Inc (NYSE:NASDAQ:SHOP) and Toas... Full story

Yahoo Finance • 4 months ago

Cathie Wood's ARK ETF buys AMD and Robinhood, sells Circle Internet

Cathie Wood’s ARK ETFs have made notable moves in the stock market on Monday, June 23, 2025, with significant transactions that reflect the investment firm’s latest strategies. The largest trade of the day was the sale of Circle Internet... Full story

Yahoo Finance • 4 months ago

Cathie Wood's ARK buys AMD and sells CRCL stock in daily trades

Cathie Wood’s ARK ETFs have disclosed their daily trades for Friday, June 20th, 2025, revealing a series of significant transactions in the tech and biotech sectors. The most substantial move was the sale of shares in Circle Internet Group... Full story

Yahoo Finance • 4 months ago

Cathie Wood's ARK buys BWX stock, sells Adaptive Biotech

Cathie Wood’s ARK ETFs have made their latest round of daily trades for Wednesday, June 18th, 2025, with BWX Technologies Inc (NYSE:BWXT) and Veracyte Inc (NASDAQ:VCYT) topping the buy list, while Adaptive Biotechnologies Corp (NASDAQ:... Full story

Yahoo Finance • 4 months ago

Cathie Wood Big Sell-Off: Tesla and Palantir Holdings Dumped

June 3 - Cathie Wood's Ark Invest sold 1,594 shares of Tesla Inc (NASDAQ:TSLA) through its ARK Innovation ETF (ARKK), offloading a position worth $546,247, according to a Monday disclosure. The move comes as Tesla faces growing pressure f... Full story

Yahoo Finance • 4 months ago

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

SEATTLE, May 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose... Full story

Yahoo Finance • 4 months ago

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose... Full story

Yahoo Finance • 5 months ago

Sector Update: Health Care Stocks Higher Friday Afternoon

Health care stocks advanced Friday afternoon with the NYSE Health Care Index rising 1.6% and the Hea PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 months ago

Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ...

Total Revenue: $52.4 million, representing 25% growth from the same period last year. MRD Revenue: $43.7 million, a 34% increase versus prior year. Immune Medicine Revenue: $8.7 million, down 6% from a year ago. Sequencing Gross Margin: Im... Full story